Long-term control of lung metastasis of tongue cancer treated effectively with cetuximab combination chemotherapy

被引:0
|
作者
Terabe, T. [1 ,2 ]
Ishibashi-Kanno, N. [1 ,3 ]
Uchida, F. [1 ]
Bukawa, H. [1 ]
机构
[1] Univ Tsukuba, Inst Med, Dept Oral & Maxillofacial Surg, Tsukuba, Ibaraki, Japan
[2] Ishioka Daiichi Hosp, Dept Dent & Oral Maxillofacial Surg, Ibaraki, Japan
[3] Univ Tsukuba, Inst Med, Dept Oral & Maxillofacial Surg, Tennodai 1-1-1, Tsukuba, Ibaraki 3058575, Japan
关键词
Tongue cancer; Neoplasm metastasis; Cetuximab; Oral squamous cell carcinoma; Head and neck squamous cell carcinoma; SQUAMOUS-CELL CARCINOMA; PLUS CETUXIMAB; 1ST-LINE TREATMENT; HEAD; NECK; CISPLATIN; RADIOTHERAPY; DOCETAXEL;
D O I
10.1016/j.ijom.2023.07.001
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Generally, systemic chemotherapy is indicated for oral squamous cell carcinoma with distant metastasis and has a poor prognosis. Recently, the advent of molecular targeted drugs, such as cetuximab and immune checkpoint inhibitors, has dramatically improved prognosis, though controlling distant metastasis remains challenging. We report a case of tongue cancer in which lung metastases disappeared in the long term. A 60-year-old Japanese male with squamous cell carcinoma of the tongue underwent preoperative chemoradiotherapy and surgery including subtotal glossectomy, bilateral modified radical neck dissection, and immediate reconstruction with an anterolateral thigh flap. One month after surgery, multiple nodules less than 10 mm in diameter appeared in both lungs on CT imaging. Multiple lung metastases were diagnosed with no local recurrence or regional lymph node metastasis. The patient continues to receive a 4-week treatment course of chemotherapy that included cetuximab every 3 months and the lung metastases were markedly reduced in size or had disappeared. No local recurrence or newly emerged metastases were observed. The patient has been doing well for nine years since the appearance of the lung metastases.
引用
收藏
页码:1221 / 1224
页数:4
相关论文
共 50 条
  • [21] Long-term survival of patients with sarcomatoid renal cell cancer treated with chemotherapy
    Dutcher, Janice P.
    Nanus, David
    MEDICAL ONCOLOGY, 2011, 28 (04) : 1530 - 1533
  • [22] Sexual Functioning in Long-Term Breast Cancer Survivors Treated with Adjuvant Chemotherapy
    Jo A. Broeckel
    Christina L. Thors
    Paul B. Jacobsen
    Margaret Small
    Charles E. Cox
    Breast Cancer Research and Treatment, 2002, 75 : 241 - 248
  • [23] LONG-TERM SURVIVAL OF PATIENTS WITH UNRESECTABLE COLORECTAL CANCER TREATED WITH NEOADJUVANT CHEMOTHERAPY
    Susana, Redondo
    Pilar, Modamio
    Salvador, Quintana
    Fernandez Cecilia, Lastra
    Eduardo L, Marino
    ATENCION FARMACEUTICA, 2012, 14 (04): : 238 - +
  • [24] Long-term survival of a patient with small-cell lung cancer (SCLC) following treatment with thalidomide and combination chemotherapy
    Mall J.W.
    Philipp A.W.
    Mall W.
    Pollmann C.
    Angiogenesis, 2002, 5 (1-2) : 11 - 13
  • [25] Bilateral pneumothorax in combination therapy with cetuximab for oral cancer with no lung metastasis: A case report
    Ehara, Yuichi
    Motohashi, Masayuki
    Naganawa, Koshuke
    Ukai, Akira
    Taniguchi, Takuya
    Muramatsu, Yasunori
    ORAL SCIENCE INTERNATIONAL, 2024, 21 (01) : 131 - 136
  • [26] EFFECTS OF LONG-TERM COMBINATION CHEMOTHERAPY ON THE RETICULOENDOTHELIAL SYSTEM
    DOMELLOF, L
    ATHLIN, L
    BERGHEM, L
    CANCER, 1984, 53 (10) : 2073 - 2078
  • [28] Patient with advanced intrahepatic cholangiocarcinoma with long-term survival successfully treated with a combination of surgery and chemotherapy
    Morise, Zenichi
    Sugioka, Atsushi
    Hoshimoto, Sojun
    Kato, Takazumi
    Tanahashi, Yoshinao
    Ikeda, Masahiro
    Kagawa, Tadashi
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY, 2008, 15 (05): : 545 - 548
  • [29] MutS Homologue 2 and the Long-term Benefit of Adjuvant Chemotherapy in Lung Cancer
    Kamal, Nermine S.
    Soria, Jean-Charles
    Mendiboure, Jean
    Planchard, David
    Olaussen, Ken A.
    Rousseau, Vanessa
    Popper, Helmut
    Pirker, Robert
    Bertrand, Pascale
    Dunant, Ariane
    Le Chevalier, Thierry
    Filipits, Martin
    Fouret, Pierre
    CLINICAL CANCER RESEARCH, 2010, 16 (04) : 1206 - 1215
  • [30] LONG-TERM INTERMITTENT ADJUVANT CHEMOTHERAPY FOR PRIMARY, RESECTED LUNG-CANCER
    KATSUKI, H
    SHIMADA, K
    KOYAMA, A
    OKITA, M
    YAMAGUCHI, Y
    OKAMOTO, T
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1975, 70 (04): : 590 - 605